As competition in the digital health space intensifies and failures become more common, earning regulatory approval and clinical acceptance of new products is more important than ever. Digital clinical trials can show regulators and clinicians how a digital health product can improve the lives of patients, and these trials need access to high-quality, real-world data (RWD).
How digital health companies can leverage unstructured data in clinical evidence generation (zs.com)
Comments